

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of interleukin-12 production (GO:0032695) | 5.12687268 |
| 2 | response to peptidoglycan (GO:0032494) | 5.04260339 |
| 3 | vascular endothelial growth factor signaling pathway (GO:0038084) | 4.89963156 |
| 4 | regulation of vitamin D biosynthetic process (GO:0060556) | 4.88248211 |
| 5 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 4.47297174 |
| 6 | positive regulation of heat generation (GO:0031652) | 4.29390790 |
| 7 | regulation of fever generation (GO:0031620) | 4.18739989 |
| 8 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 4.14166447 |
| 9 | lymphangiogenesis (GO:0001946) | 4.13879951 |
| 10 | lymph vessel development (GO:0001945) | 4.02134588 |
| 11 | NIK/NF-kappaB signaling (GO:0038061) | 4.00721658 |
| 12 | positive regulation of chemokine biosynthetic process (GO:0045080) | 4.00045887 |
| 13 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.94236532 |
| 14 | Notch signaling involved in heart development (GO:0061314) | 3.91492863 |
| 15 | microglial cell activation (GO:0001774) | 3.91010141 |
| 16 | detection of molecule of bacterial origin (GO:0032490) | 3.90101566 |
| 17 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 3.87333214 |
| 18 | T-helper 1 type immune response (GO:0042088) | 3.83751504 |
| 19 | regulation of mononuclear cell migration (GO:0071675) | 3.82929584 |
| 20 | regulation of cytokine secretion involved in immune response (GO:0002739) | 3.78840984 |
| 21 | positive regulation of astrocyte differentiation (GO:0048711) | 3.68299771 |
| 22 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 3.66947135 |
| 23 | regulation of podosome assembly (GO:0071801) | 3.66853943 |
| 24 | regulation of vitamin metabolic process (GO:0030656) | 3.63337054 |
| 25 | myeloid dendritic cell differentiation (GO:0043011) | 3.62460095 |
| 26 | regulation of chronic inflammatory response (GO:0002676) | 3.59837023 |
| 27 | regulation of chemokine biosynthetic process (GO:0045073) | 3.58119876 |
| 28 | neutrophil activation involved in immune response (GO:0002283) | 3.57275669 |
| 29 | endothelium development (GO:0003158) | 3.54083017 |
| 30 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 3.51400251 |
| 31 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.51264557 |
| 32 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 3.51122153 |
| 33 | leukocyte tethering or rolling (GO:0050901) | 3.47682064 |
| 34 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.46123233 |
| 35 | hyaluronan catabolic process (GO:0030214) | 3.44572643 |
| 36 | negative regulation of smooth muscle cell migration (GO:0014912) | 3.41602028 |
| 37 | basement membrane organization (GO:0071711) | 3.38391435 |
| 38 | keratan sulfate catabolic process (GO:0042340) | 3.37222384 |
| 39 | cell adhesion mediated by integrin (GO:0033627) | 3.36980402 |
| 40 | sexual reproduction (GO:0019953) | 3.34201778 |
| 41 | chondroitin sulfate catabolic process (GO:0030207) | 3.32247381 |
| 42 | monocyte chemotaxis (GO:0002548) | 3.32037895 |
| 43 | type I interferon signaling pathway (GO:0060337) | 3.31626409 |
| 44 | cellular response to type I interferon (GO:0071357) | 3.31626409 |
| 45 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 3.30545716 |
| 46 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 3.28579181 |
| 47 | positive regulation of interferon-alpha production (GO:0032727) | 3.28185092 |
| 48 | growth hormone receptor signaling pathway (GO:0060396) | 3.27771597 |
| 49 | cell migration involved in gastrulation (GO:0042074) | 3.27186926 |
| 50 | macrophage activation involved in immune response (GO:0002281) | 3.26135110 |
| 51 | response to type I interferon (GO:0034340) | 3.23808166 |
| 52 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.23299208 |
| 53 | endodermal cell differentiation (GO:0035987) | 3.23288618 |
| 54 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.23067997 |
| 55 | response to protozoan (GO:0001562) | 3.22200457 |
| 56 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.21723558 |
| 57 | positive regulation of antigen processing and presentation (GO:0002579) | 3.21529414 |
| 58 | germinal center formation (GO:0002467) | 3.21396190 |
| 59 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 3.20600577 |
| 60 | morphogenesis of an endothelium (GO:0003159) | 3.20299525 |
| 61 | endothelial tube morphogenesis (GO:0061154) | 3.20299525 |
| 62 | ruffle organization (GO:0031529) | 3.18873354 |
| 63 | glycosphingolipid catabolic process (GO:0046479) | 3.18744121 |
| 64 | regulation of macrophage chemotaxis (GO:0010758) | 3.16770260 |
| 65 | low-density lipoprotein particle clearance (GO:0034383) | 3.16014708 |
| 66 | immunoglobulin mediated immune response (GO:0016064) | 3.14956377 |
| 67 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.14270137 |
| 68 | cellular response to lipopolysaccharide (GO:0071222) | 3.13001503 |
| 69 | dermatan sulfate metabolic process (GO:0030205) | 3.11886247 |
| 70 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.11395331 |
| 71 | regulation of interferon-alpha production (GO:0032647) | 3.09831071 |
| 72 | defense response to protozoan (GO:0042832) | 3.09215973 |
| 73 | wound healing, spreading of epidermal cells (GO:0035313) | 3.08822719 |
| 74 | regulation of heat generation (GO:0031650) | 3.08499055 |
| 75 | myeloid dendritic cell activation (GO:0001773) | 3.08342375 |
| 76 | regulation of nitric oxide biosynthetic process (GO:0045428) | 3.08278583 |
| 77 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.06782652 |
| 78 | cellular response to molecule of bacterial origin (GO:0071219) | 3.05820347 |
| 79 | regulation of cholesterol storage (GO:0010885) | 3.04110384 |
| 80 | adhesion of symbiont to host (GO:0044406) | 3.03769167 |
| 81 | positive regulation by symbiont of host defense response (GO:0052509) | 3.01601984 |
| 82 | modulation by symbiont of host defense response (GO:0052031) | 3.01601984 |
| 83 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.01601984 |
| 84 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.01601984 |
| 85 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.01601984 |
| 86 | modulation by symbiont of host immune response (GO:0052553) | 3.01601984 |
| 87 | activation of MAPKKK activity (GO:0000185) | 3.00847396 |
| 88 | apoptotic cell clearance (GO:0043277) | 3.00506150 |
| 89 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.99704825 |
| 90 | cell migration involved in heart development (GO:0060973) | 2.98381645 |
| 91 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.96797056 |
| 92 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.96220932 |
| 93 | negative regulation of cell killing (GO:0031342) | 2.96220932 |
| 94 | branching involved in salivary gland morphogenesis (GO:0060445) | 2.95653256 |
| 95 | oligosaccharide catabolic process (GO:0009313) | 2.95306185 |
| 96 | granulocyte activation (GO:0036230) | 2.95022274 |
| 97 | protein localization to endosome (GO:0036010) | 2.94733310 |
| 98 | branching involved in labyrinthine layer morphogenesis (GO:0060670) | 2.93434741 |
| 99 | positive regulation of epithelial to mesenchymal transition (GO:0010718) | 2.92932389 |
| 100 | positive regulation of interleukin-6 production (GO:0032755) | 2.92881041 |
| 101 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.92727078 |
| 102 | positive regulation of nitric oxide biosynthetic process (GO:0045429) | 2.91046715 |
| 103 | wound healing, spreading of cells (GO:0044319) | 2.90706719 |
| 104 | adhesion of symbiont to host cell (GO:0044650) | 2.90234375 |
| 105 | virion attachment to host cell (GO:0019062) | 2.90234375 |
| 106 | positive regulation of acute inflammatory response (GO:0002675) | 2.88783986 |
| 107 | detection of external biotic stimulus (GO:0098581) | 2.88396845 |
| 108 | regulation of interleukin-12 production (GO:0032655) | 2.87546526 |
| 109 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.86285316 |
| 110 | regulation of antigen processing and presentation (GO:0002577) | 2.85607006 |
| 111 | regulation of toll-like receptor 4 signaling pathway (GO:0034143) | 2.84328116 |
| 112 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.83036049 |
| 113 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.82142519 |
| 114 | regulation of RIG-I signaling pathway (GO:0039535) | 2.79733504 |
| 115 | dendritic cell differentiation (GO:0097028) | 2.79522890 |
| 116 | negative regulation of production of molecular mediator of immune response (GO:0002701) | 2.79283792 |
| 117 | neuron projection extension involved in neuron projection guidance (GO:1902284) | 2.79137838 |
| 118 | axon extension involved in axon guidance (GO:0048846) | 2.79137838 |
| 119 | glycolipid catabolic process (GO:0019377) | 2.78626579 |
| 120 | positive regulation of type 2 immune response (GO:0002830) | 2.77289044 |
| 121 | regulation of NF-kappaB import into nucleus (GO:0042345) | 2.75890631 |
| 122 | response to muramyl dipeptide (GO:0032495) | 2.74969718 |
| 123 | amino sugar catabolic process (GO:0046348) | 2.74924237 |
| 124 | endothelial cell morphogenesis (GO:0001886) | 2.74688632 |
| 125 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 2.73722675 |
| 126 | dermatan sulfate biosynthetic process (GO:0030208) | 2.73459370 |
| 127 | negative regulation of lipid storage (GO:0010888) | 2.71227373 |
| 128 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.71091027 |
| 129 | response to fluid shear stress (GO:0034405) | 2.70989194 |
| 130 | glial cell migration (GO:0008347) | 2.69587365 |
| 131 | detection of other organism (GO:0098543) | 2.69527949 |
| 132 | regulation of interleukin-6 production (GO:0032675) | 2.68941534 |
| 133 | regulation of cell migration involved in sprouting angiogenesis (GO:0090049) | 2.68014071 |
| 134 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.67428106 |
| 135 | cellular response to biotic stimulus (GO:0071216) | 2.67137665 |
| 136 | regulation of tight junction assembly (GO:2000810) | 2.66504655 |
| 137 | urate metabolic process (GO:0046415) | 2.65868762 |
| 138 | vitamin catabolic process (GO:0009111) | 2.64611169 |
| 139 | fat-soluble vitamin catabolic process (GO:0042363) | 2.64611169 |
| 140 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition | 2.64372282 |
| 141 | regulation of interferon-gamma biosynthetic process (GO:0045072) | 2.63813961 |
| 142 | detection of biotic stimulus (GO:0009595) | 2.63477072 |
| 143 | positive regulation vascular endothelial growth factor production (GO:0010575) | 2.62711802 |
| 144 | cellular response to growth hormone stimulus (GO:0071378) | 2.62340874 |
| 145 | response to laminar fluid shear stress (GO:0034616) | 2.61360095 |
| 146 | vagina development (GO:0060068) | 2.60841143 |
| 147 | blood vessel endothelial cell migration (GO:0043534) | 2.59157761 |
| 148 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.58395819 |
| 149 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.57862227 |
| 150 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.57577281 |
| 151 | positive regulation of interleukin-10 production (GO:0032733) | 2.57089246 |
| 152 | aorta morphogenesis (GO:0035909) | 2.56975964 |
| 153 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.56924200 |
| 154 | positive regulation of interferon-beta production (GO:0032728) | 2.56863065 |
| 155 | regulation of type 2 immune response (GO:0002828) | 2.55891204 |
| 156 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.55640518 |
| 157 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531) | 2.55170111 |
| 158 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 2.54834325 |
| 159 | regulation of chemokine-mediated signaling pathway (GO:0070099) | 2.53883443 |
| 160 | negative regulation of blood vessel endothelial cell migration (GO:0043537) | 2.51732053 |
| 161 | regulation of monocyte chemotaxis (GO:0090025) | 2.51048805 |
| 162 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 2.50206595 |
| 163 | macrophage chemotaxis (GO:0048246) | 2.48923578 |
| 164 | regulation of integrin activation (GO:0033623) | 2.48292741 |
| 165 | positive regulation of endothelial cell differentiation (GO:0045603) | 2.46106030 |
| 166 | cell migration involved in sprouting angiogenesis (GO:0002042) | 2.45482491 |
| 167 | substrate-dependent cell migration (GO:0006929) | 2.42447557 |
| 168 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.41783966 |
| 169 | negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948) | 2.37669798 |
| 170 | vasculogenesis (GO:0001570) | 2.36498558 |
| 171 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.36490692 |
| 172 | substrate adhesion-dependent cell spreading (GO:0034446) | 2.36417955 |
| 173 | surfactant homeostasis (GO:0043129) | 2.35786839 |
| 174 | regulation of endothelial cell differentiation (GO:0045601) | 2.34267542 |
| 175 | positive regulation of interleukin-12 production (GO:0032735) | 2.34246446 |
| 176 | regulation of macrophage cytokine production (GO:0010935) | 2.32606595 |
| 177 | macrophage activation (GO:0042116) | 2.32604865 |
| 178 | positive regulation of tyrosine phosphorylation of Stat1 protein (GO:0042511) | 2.32526576 |
| 179 | endothelial cell differentiation (GO:0045446) | 2.31873625 |
| 180 | positive regulation of adherens junction organization (GO:1903393) | 2.31139592 |
| 181 | positive regulation of cell junction assembly (GO:1901890) | 2.30338043 |
| 182 | positive regulation of focal adhesion assembly (GO:0051894) | 2.30338043 |
| 183 | patterning of blood vessels (GO:0001569) | 2.30211743 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 4.20359041 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.19209542 |
| 3 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.86066123 |
| 4 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.82021939 |
| 5 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.59659643 |
| 6 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 3.40017911 |
| 7 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 3.31285334 |
| 8 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.18103120 |
| 9 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.98825575 |
| 10 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.95247015 |
| 11 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.86964944 |
| 12 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 2.85298498 |
| 13 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.75337101 |
| 14 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.49437199 |
| 15 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.47891959 |
| 16 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 2.38159496 |
| 17 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.30627739 |
| 18 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.22142214 |
| 19 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.20530319 |
| 20 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 2.19554941 |
| 21 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.09654149 |
| 22 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.09443433 |
| 23 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.03963282 |
| 24 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 2.03842517 |
| 25 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.00910386 |
| 26 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.98333264 |
| 27 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.98312843 |
| 28 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.87349396 |
| 29 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.84551342 |
| 30 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.80527883 |
| 31 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.76240104 |
| 32 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.74860923 |
| 33 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.71619990 |
| 34 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.65020625 |
| 35 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.64817261 |
| 36 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.59349364 |
| 37 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.58223091 |
| 38 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.56477212 |
| 39 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.54761327 |
| 40 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.53954751 |
| 41 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.52615649 |
| 42 | * ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.51720137 |
| 43 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.50551351 |
| 44 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.50170552 |
| 45 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.49914150 |
| 46 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.49358079 |
| 47 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.47161821 |
| 48 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.45909705 |
| 49 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.43813281 |
| 50 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.43711453 |
| 51 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.43406073 |
| 52 | CJUN_26792858_Chip-Seq_BT549_Human | 1.38776922 |
| 53 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.38312567 |
| 54 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.38312567 |
| 55 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.38312567 |
| 56 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.36743104 |
| 57 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.36589943 |
| 58 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.34346280 |
| 59 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.34259627 |
| 60 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.33753681 |
| 61 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.33210761 |
| 62 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.32776508 |
| 63 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.32153090 |
| 64 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.31810752 |
| 65 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.31683173 |
| 66 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.31677614 |
| 67 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.31278513 |
| 68 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.31237577 |
| 69 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.31080236 |
| 70 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.31080236 |
| 71 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.30735344 |
| 72 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.28746760 |
| 73 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.28371484 |
| 74 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.28288511 |
| 75 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.27942279 |
| 76 | ATF3_27146783_Chip-Seq_COLON_Human | 1.27096834 |
| 77 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.26345203 |
| 78 | UTX_26944678_Chip-Seq_JUKART_Human | 1.26045128 |
| 79 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.24739975 |
| 80 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.24500716 |
| 81 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.24246742 |
| 82 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.23372351 |
| 83 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.21870838 |
| 84 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.21694012 |
| 85 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.21487622 |
| 86 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.21456086 |
| 87 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.19384520 |
| 88 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.18644270 |
| 89 | MAF_26560356_Chip-Seq_TH2_Human | 1.17766229 |
| 90 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.17248184 |
| 91 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.14949590 |
| 92 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.14792099 |
| 93 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.14538564 |
| 94 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.14453800 |
| 95 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.13639454 |
| 96 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.13313398 |
| 97 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.12381213 |
| 98 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.12350737 |
| 99 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.12149894 |
| 100 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.11835665 |
| 101 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.10719113 |
| 102 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.10640443 |
| 103 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.09946926 |
| 104 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.09766382 |
| 105 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.09766382 |
| 106 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.09307029 |
| 107 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.08896366 |
| 108 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.08459953 |
| 109 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.07644946 |
| 110 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.07586964 |
| 111 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.07430671 |
| 112 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.07383772 |
| 113 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.06268589 |
| 114 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.05712469 |
| 115 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.05451437 |
| 116 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.05312325 |
| 117 | MAF_26560356_Chip-Seq_TH1_Human | 1.04222727 |
| 118 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.04146997 |
| 119 | * UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.03293284 |
| 120 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.02616948 |
| 121 | MYC_22102868_ChIP-Seq_BL_Human | 1.02430455 |
| 122 | MYB_26560356_Chip-Seq_TH2_Human | 1.02030960 |
| 123 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.01399630 |
| 124 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.00964634 |
| 125 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.00929430 |
| 126 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.00481763 |
| 127 | SPI1_23127762_ChIP-Seq_K562_Human | 0.98116392 |
| 128 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.97375748 |
| 129 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.97071838 |
| 130 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.96936968 |
| 131 | GATA1_19941826_ChIP-Seq_K562_Human | 0.96349671 |
| 132 | MYB_26560356_Chip-Seq_TH1_Human | 0.96324684 |
| 133 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.95784041 |
| 134 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 0.95076172 |
| 135 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.94554795 |
| 136 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.94130396 |
| 137 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.93874061 |
| 138 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.92430804 |
| 139 | KDM2B_26808549_Chip-Seq_K562_Human | 0.88806300 |
| 140 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.86406681 |
| 141 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.85848779 |
| 142 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 0.85796415 |
| 143 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.85384267 |
| 144 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 0.83707997 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0010368_abnormal_lymphatic_system | 4.35321741 |
| 2 | MP0008438_abnormal_cutaneous_collagen | 3.81758223 |
| 3 | MP0003279_aneurysm | 3.18411271 |
| 4 | MP0001879_abnormal_lymphatic_vessel | 2.95483132 |
| 5 | MP0003705_abnormal_hypodermis_morpholog | 2.95380228 |
| 6 | MP0006054_spinal_hemorrhage | 2.94251514 |
| 7 | MP0004272_abnormal_basement_membrane | 2.55610275 |
| 8 | MP0003724_increased_susceptibility_to | 2.47808133 |
| 9 | MP0005451_abnormal_body_composition | 2.46583182 |
| 10 | MP0003300_gastrointestinal_ulcer | 2.38161591 |
| 11 | MP0001958_emphysema | 2.35184479 |
| 12 | MP0005025_abnormal_response_to | 2.22618220 |
| 13 | MP0003303_peritoneal_inflammation | 2.19097832 |
| 14 | MP0005058_abnormal_lysosome_morphology | 2.16295291 |
| 15 | MP0003091_abnormal_cell_migration | 2.15159958 |
| 16 | MP0002139_abnormal_hepatobiliary_system | 2.07761679 |
| 17 | MP0000767_abnormal_smooth_muscle | 2.07584919 |
| 18 | MP0001915_intracranial_hemorrhage | 2.03326648 |
| 19 | MP0009384_cardiac_valve_regurgitation | 2.03254665 |
| 20 | MP0001835_abnormal_antigen_presentation | 2.00443028 |
| 21 | MP0006082_CNS_inflammation | 1.99537784 |
| 22 | MP0002254_reproductive_system_inflammat | 1.95657401 |
| 23 | MP0003566_abnormal_cell_adhesion | 1.86448611 |
| 24 | MP0000604_amyloidosis | 1.85740103 |
| 25 | MP0004510_myositis | 1.84300325 |
| 26 | MP0002138_abnormal_hepatobiliary_system | 1.83134307 |
| 27 | MP0004947_skin_inflammation | 1.81205107 |
| 28 | MP0008004_abnormal_stomach_pH | 1.81201016 |
| 29 | MP0001853_heart_inflammation | 1.72544402 |
| 30 | MP0009278_abnormal_bone_marrow | 1.64217828 |
| 31 | MP0002420_abnormal_adaptive_immunity | 1.61288335 |
| 32 | MP0001819_abnormal_immune_cell | 1.60795243 |
| 33 | MP0001845_abnormal_inflammatory_respons | 1.60388869 |
| 34 | MP0000343_altered_response_to | 1.58593763 |
| 35 | MP0005670_abnormal_white_adipose | 1.50429711 |
| 36 | MP0005275_abnormal_skin_tensile | 1.49134933 |
| 37 | MP0005167_abnormal_blood-brain_barrier | 1.46740809 |
| 38 | MP0008260_abnormal_autophagy | 1.45783991 |
| 39 | MP0003191_abnormal_cellular_cholesterol | 1.45088328 |
| 40 | MP0010155_abnormal_intestine_physiology | 1.44224441 |
| 41 | MP0002405_respiratory_system_inflammati | 1.42005004 |
| 42 | MP0000685_abnormal_immune_system | 1.40462533 |
| 43 | MP0005166_decreased_susceptibility_to | 1.37918199 |
| 44 | MP0005623_abnormal_meninges_morphology | 1.36632084 |
| 45 | MP0000733_abnormal_muscle_development | 1.31953047 |
| 46 | MP0009840_abnormal_foam_cell | 1.31745343 |
| 47 | MP0005023_abnormal_wound_healing | 1.29445253 |
| 48 | MP0004858_abnormal_nervous_system | 1.29153995 |
| 49 | MP0009333_abnormal_splenocyte_physiolog | 1.27956745 |
| 50 | MP0001545_abnormal_hematopoietic_system | 1.27734351 |
| 51 | MP0005397_hematopoietic_system_phenotyp | 1.27734351 |
| 52 | MP0002295_abnormal_pulmonary_circulatio | 1.26135974 |
| 53 | MP0002332_abnormal_exercise_endurance | 1.23106406 |
| 54 | MP0005257_abnormal_intraocular_pressure | 1.22220509 |
| 55 | MP0001533_abnormal_skeleton_physiology | 1.22197225 |
| 56 | MP0002148_abnormal_hypersensitivity_rea | 1.22168750 |
| 57 | MP0002419_abnormal_innate_immunity | 1.20712445 |
| 58 | MP0003075_altered_response_to | 1.20639491 |
| 59 | MP0005310_abnormal_salivary_gland | 1.19324582 |
| 60 | MP0008007_abnormal_cellular_replicative | 1.18408748 |
| 61 | MP0004883_abnormal_blood_vessel | 1.17773176 |
| 62 | MP0000013_abnormal_adipose_tissue | 1.17340352 |
| 63 | MP0000716_abnormal_immune_system | 1.15329636 |
| 64 | MP0005164_abnormal_response_to | 1.15034817 |
| 65 | MP0004084_abnormal_cardiac_muscle | 1.13696042 |
| 66 | MP0001614_abnormal_blood_vessel | 1.12820587 |
| 67 | MP0005508_abnormal_skeleton_morphology | 1.12613909 |
| 68 | MP0003448_altered_tumor_morphology | 1.12025173 |
| 69 | MP0010352_gastrointestinal_tract_polyps | 1.11334126 |
| 70 | MP0000249_abnormal_blood_vessel | 1.09107411 |
| 71 | MP0005076_abnormal_cell_differentiation | 1.08660626 |
| 72 | MP0003045_fibrosis | 1.08061359 |
| 73 | MP0001851_eye_inflammation | 1.06889127 |
| 74 | MP0002925_abnormal_cardiovascular_devel | 1.03250678 |
| 75 | MP0003806_abnormal_nucleotide_metabolis | 1.02255690 |
| 76 | MP0003172_abnormal_lysosome_physiology | 1.02193747 |
| 77 | MP0002877_abnormal_melanocyte_morpholog | 1.01880846 |
| 78 | MP0005165_increased_susceptibility_to | 1.01498167 |
| 79 | MP0002128_abnormal_blood_circulation | 1.01456189 |
| 80 | MP0003385_abnormal_body_wall | 1.01169735 |
| 81 | MP0005390_skeleton_phenotype | 0.98845250 |
| 82 | MP0002452_abnormal_antigen_presenting | 0.98588574 |
| 83 | MP0003436_decreased_susceptibility_to | 0.98134127 |
| 84 | MP0002998_abnormal_bone_remodeling | 0.96452022 |
| 85 | MP0009763_increased_sensitivity_to | 0.95896746 |
| 86 | MP0002932_abnormal_joint_morphology | 0.94610566 |
| 87 | MP0003656_abnormal_erythrocyte_physiolo | 0.94015806 |
| 88 | MP0005503_abnormal_tendon_morphology | 0.93723776 |
| 89 | MP0002398_abnormal_bone_marrow | 0.93615212 |
| 90 | MP0000163_abnormal_cartilage_morphology | 0.92797412 |
| 91 | MP0006138_congestive_heart_failure | 0.92740312 |
| 92 | MP0000858_altered_metastatic_potential | 0.92573973 |
| 93 | MP0002089_abnormal_postnatal_growth/wei | 0.92045426 |
| 94 | MP0004808_abnormal_hematopoietic_stem | 0.91873559 |
| 95 | MP0002933_joint_inflammation | 0.91740101 |
| 96 | MP0005595_abnormal_vascular_smooth | 0.90216865 |
| 97 | MP0003329_amyloid_beta_deposits | 0.89759674 |
| 98 | MP0002429_abnormal_blood_cell | 0.88812743 |
| 99 | MP0001790_abnormal_immune_system | 0.86070626 |
| 100 | MP0005387_immune_system_phenotype | 0.86070626 |
| 101 | MP0003453_abnormal_keratinocyte_physiol | 0.85774326 |
| 102 | MP0008874_decreased_physiological_sensi | 0.84930166 |
| 103 | MP0000689_abnormal_spleen_morphology | 0.84075966 |
| 104 | MP0005000_abnormal_immune_tolerance | 0.81997742 |
| 105 | MP0003828_pulmonary_edema | 0.81584417 |
| 106 | MP0000920_abnormal_myelination | 0.81449814 |
| 107 | MP0001663_abnormal_digestive_system | 0.79840208 |
| 108 | MP0002113_abnormal_skeleton_development | 0.79381568 |
| 109 | MP0001542_abnormal_bone_strength | 0.78977874 |
| 110 | MP0002115_abnormal_skeleton_extremities | 0.78802824 |
| 111 | MP0002653_abnormal_ependyma_morphology | 0.78632495 |
| 112 | MP0008469_abnormal_protein_level | 0.78574714 |
| 113 | MP0002136_abnormal_kidney_physiology | 0.77510531 |
| 114 | MP0002722_abnormal_immune_system | 0.76993153 |
| 115 | MP0009785_altered_susceptibility_to | 0.76921107 |
| 116 | MP0009765_abnormal_xenobiotic_induced | 0.76284009 |
| 117 | MP0005464_abnormal_platelet_physiology | 0.76011748 |
| 118 | MP0005360_urolithiasis | 0.75283316 |
| 119 | MP0001849_ear_inflammation | 0.74256711 |
| 120 | MP0009764_decreased_sensitivity_to | 0.74182533 |
| 121 | MP0005197_abnormal_uvea_morphology | 0.73979106 |
| 122 | MP0010030_abnormal_orbit_morphology | 0.73950078 |
| 123 | MP0004185_abnormal_adipocyte_glucose | 0.73402002 |
| 124 | MP0002277_abnormal_respiratory_mucosa | 0.72192341 |
| 125 | MP0001873_stomach_inflammation | 0.72106194 |
| 126 | MP0002135_abnormal_kidney_morphology | 0.71946682 |
| 127 | MP0001800_abnormal_humoral_immune | 0.71904705 |
| 128 | MP0003795_abnormal_bone_structure | 0.71831713 |
| 129 | MP0003690_abnormal_glial_cell | 0.71656740 |
| 130 | MP0005671_abnormal_response_to | 0.71495914 |
| 131 | MP0002723_abnormal_immune_serum | 0.69691774 |
| 132 | MP0003221_abnormal_cardiomyocyte_apopto | 0.69540700 |
| 133 | MP0005666_abnormal_adipose_tissue | 0.69535107 |
| 134 | MP0000465_gastrointestinal_hemorrhage | 0.69183596 |
| 135 | MP0003763_abnormal_thymus_physiology | 0.64749572 |
| 136 | MP0003195_calcinosis | 0.63783856 |
| 137 | MP0000750_abnormal_muscle_regeneration | 0.63396670 |
| 138 | MP0005319_abnormal_enzyme/_coenzyme | 0.57295756 |
| 139 | MP0003634_abnormal_glial_cell | 0.57155929 |
| 140 | MP0005647_abnormal_sex_gland | 0.53773705 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Protrusio acetabuli (HP:0003179) | 5.04380989 |
| 2 | Arterial tortuosity (HP:0005116) | 5.02391512 |
| 3 | Vascular tortuosity (HP:0004948) | 4.89760691 |
| 4 | Abnormality of macrophages (HP:0004311) | 4.87144456 |
| 5 | Systemic lupus erythematosus (HP:0002725) | 4.83307224 |
| 6 | Increased cerebral lipofuscin (HP:0011813) | 4.46318942 |
| 7 | Premature rupture of membranes (HP:0001788) | 4.43049908 |
| 8 | Optic neuritis (HP:0100653) | 4.32982179 |
| 9 | Retrobulbar optic neuritis (HP:0100654) | 4.32982179 |
| 10 | Cerebral aneurysm (HP:0004944) | 4.28219218 |
| 11 | Loss of speech (HP:0002371) | 4.25112104 |
| 12 | Cervical subluxation (HP:0003308) | 4.08024798 |
| 13 | Aortic aneurysm (HP:0004942) | 4.05608897 |
| 14 | Myositis (HP:0100614) | 3.98284254 |
| 15 | Recurrent abscess formation (HP:0002722) | 3.97529739 |
| 16 | Mediastinal lymphadenopathy (HP:0100721) | 3.95388765 |
| 17 | Aortic dissection (HP:0002647) | 3.88095612 |
| 18 | Disinhibition (HP:0000734) | 3.81002959 |
| 19 | Hematochezia (HP:0002573) | 3.76712914 |
| 20 | Stomatitis (HP:0010280) | 3.70972578 |
| 21 | Peritonitis (HP:0002586) | 3.66988522 |
| 22 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.52033423 |
| 23 | Nuclear cataract (HP:0100018) | 3.46595079 |
| 24 | Nonimmune hydrops fetalis (HP:0001790) | 3.45693944 |
| 25 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.43496233 |
| 26 | Neurofibrillary tangles (HP:0002185) | 3.35301653 |
| 27 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.15201973 |
| 28 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.15201973 |
| 29 | Abnormality of glycolipid metabolism (HP:0010969) | 3.15201973 |
| 30 | Glomerulonephritis (HP:0000099) | 3.10772972 |
| 31 | Shallow orbits (HP:0000586) | 3.07956482 |
| 32 | Mutism (HP:0002300) | 3.04179013 |
| 33 | Spondylolisthesis (HP:0003302) | 2.99835002 |
| 34 | Axonal loss (HP:0003447) | 2.98194019 |
| 35 | Keratoconjunctivitis sicca (HP:0001097) | 2.87139988 |
| 36 | Cortical dysplasia (HP:0002539) | 2.86921767 |
| 37 | Dysostosis multiplex (HP:0000943) | 2.80444283 |
| 38 | Aneurysm (HP:0002617) | 2.76707249 |
| 39 | Broad metatarsal (HP:0001783) | 2.76706275 |
| 40 | Soft skin (HP:0000977) | 2.69174481 |
| 41 | Amyloidosis (HP:0011034) | 2.67767207 |
| 42 | Polycythemia (HP:0001901) | 2.64160596 |
| 43 | Progressive neurologic deterioration (HP:0002344) | 2.63435371 |
| 44 | Dilatation of the ascending aorta (HP:0005111) | 2.62444611 |
| 45 | Apathy (HP:0000741) | 2.61023328 |
| 46 | Diminished motivation (HP:0000745) | 2.53589408 |
| 47 | Mitral valve prolapse (HP:0001634) | 2.51479581 |
| 48 | Keratoconjunctivitis (HP:0001096) | 2.50919518 |
| 49 | Increased serum ferritin (HP:0003281) | 2.48483746 |
| 50 | Pulmonary infiltrates (HP:0002113) | 2.48197093 |
| 51 | Short hallux (HP:0010109) | 2.45870120 |
| 52 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.44528232 |
| 53 | Complement deficiency (HP:0004431) | 2.43629264 |
| 54 | Cerebral inclusion bodies (HP:0100314) | 2.43133097 |
| 55 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.42732026 |
| 56 | Back pain (HP:0003418) | 2.41985868 |
| 57 | Purpura (HP:0000979) | 2.41169876 |
| 58 | Neuronal loss in central nervous system (HP:0002529) | 2.40977093 |
| 59 | Camptodactyly of toe (HP:0001836) | 2.39629548 |
| 60 | Vasculitis (HP:0002633) | 2.39613638 |
| 61 | Spinal muscular atrophy (HP:0007269) | 2.38620750 |
| 62 | Lymphangioma (HP:0100764) | 2.38194594 |
| 63 | Chronic obstructive pulmonary disease (HP:0006510) | 2.37521313 |
| 64 | Obstructive lung disease (HP:0006536) | 2.37521313 |
| 65 | Blue sclerae (HP:0000592) | 2.36948522 |
| 66 | Hepatosplenomegaly (HP:0001433) | 2.35809928 |
| 67 | Vertebral compression fractures (HP:0002953) | 2.35376154 |
| 68 | Upper motor neuron abnormality (HP:0002127) | 2.33675125 |
| 69 | Abnormality of the peritoneum (HP:0002585) | 2.33586224 |
| 70 | Vacuolated lymphocytes (HP:0001922) | 2.32095894 |
| 71 | Chondrocalcinosis (HP:0000934) | 2.30700781 |
| 72 | Increased IgM level (HP:0003496) | 2.27579168 |
| 73 | Bladder diverticulum (HP:0000015) | 2.27214679 |
| 74 | Striae distensae (HP:0001065) | 2.26407212 |
| 75 | Venous abnormality (HP:0002624) | 2.23844946 |
| 76 | Myocardial infarction (HP:0001658) | 2.21914662 |
| 77 | Mucopolysacchariduria (HP:0008155) | 2.21667424 |
| 78 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.21667424 |
| 79 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.21409596 |
| 80 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.21409596 |
| 81 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.21409596 |
| 82 | Esophageal varix (HP:0002040) | 2.20029789 |
| 83 | Recurrent skin infections (HP:0001581) | 2.19749682 |
| 84 | Nephritis (HP:0000123) | 2.19500039 |
| 85 | Gingivitis (HP:0000230) | 2.15743188 |
| 86 | Aplasia/Hypoplasia of the hallux (HP:0008362) | 2.15358951 |
| 87 | Hand muscle atrophy (HP:0009130) | 2.13587440 |
| 88 | Biconcave vertebral bodies (HP:0004586) | 2.13459078 |
| 89 | Asymmetric septal hypertrophy (HP:0001670) | 2.12509371 |
| 90 | Polyneuropathy (HP:0001271) | 2.12375054 |
| 91 | Inappropriate behavior (HP:0000719) | 2.11904141 |
| 92 | Gangrene (HP:0100758) | 2.11898016 |
| 93 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.11474500 |
| 94 | Agnosia (HP:0010524) | 2.10318832 |
| 95 | Joint stiffness (HP:0001387) | 2.10292275 |
| 96 | Parakeratosis (HP:0001036) | 2.09367910 |
| 97 | Interstitial pulmonary disease (HP:0006530) | 2.09122095 |
| 98 | Tetraparesis (HP:0002273) | 2.09071309 |
| 99 | Wormian bones (HP:0002645) | 2.07206484 |
| 100 | Genu recurvatum (HP:0002816) | 2.07117313 |
| 101 | Spontaneous hematomas (HP:0007420) | 2.06430786 |
| 102 | Basal ganglia calcification (HP:0002135) | 2.05436237 |
| 103 | Abnormality of Sharpey fibers (HP:0100685) | 2.04884966 |
| 104 | Venous insufficiency (HP:0005293) | 2.03950689 |
| 105 | Coxa vara (HP:0002812) | 2.03767378 |
| 106 | T lymphocytopenia (HP:0005403) | 2.03720402 |
| 107 | Ankle contracture (HP:0006466) | 2.03688318 |
| 108 | Urticaria (HP:0001025) | 2.02255330 |
| 109 | Dementia (HP:0000726) | 2.02241725 |
| 110 | Prolonged neonatal jaundice (HP:0006579) | 2.01419032 |
| 111 | Autoimmune thrombocytopenia (HP:0001973) | 2.00972225 |
| 112 | Hemoptysis (HP:0002105) | 2.00699268 |
| 113 | Pathologic fracture (HP:0002756) | 2.00537256 |
| 114 | Meningitis (HP:0001287) | 1.99623211 |
| 115 | Ovoid vertebral bodies (HP:0003300) | 1.97759139 |
| 116 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.96661804 |
| 117 | Osteolytic defects of the hand bones (HP:0009699) | 1.96661804 |
| 118 | Coxa valga (HP:0002673) | 1.96342490 |
| 119 | Gastrointestinal stroma tumor (HP:0100723) | 1.94904520 |
| 120 | Glomerulopathy (HP:0100820) | 1.94681494 |
| 121 | Petechiae (HP:0000967) | 1.93156311 |
| 122 | Abnormality of complement system (HP:0005339) | 1.92759540 |
| 123 | Disproportionate tall stature (HP:0001519) | 1.92726394 |
| 124 | Absent toe (HP:0010760) | 1.92206527 |
| 125 | Peripheral demyelination (HP:0011096) | 1.91854164 |
| 126 | Flexion contracture of toe (HP:0005830) | 1.91004362 |
| 127 | Joint contractures involving the joints of the feet (HP:0100492) | 1.91004362 |
| 128 | Recurrent viral infections (HP:0004429) | 1.90797313 |
| 129 | Neonatal short-limb short stature (HP:0008921) | 1.90096313 |
| 130 | Distal upper limb amyotrophy (HP:0007149) | 1.90008386 |
| 131 | Upper limb amyotrophy (HP:0009129) | 1.90008386 |
| 132 | Bone pain (HP:0002653) | 1.88846340 |
| 133 | Anorexia (HP:0002039) | 1.88098299 |
| 134 | Platyspondyly (HP:0000926) | 1.87918526 |
| 135 | Abnormality of the acetabulum (HP:0003170) | 1.87454993 |
| 136 | Eczematoid dermatitis (HP:0000976) | 1.86949193 |
| 137 | Wrist flexion contracture (HP:0001239) | 1.86873543 |
| 138 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.86407821 |
| 139 | Global brain atrophy (HP:0002283) | 1.85241160 |
| 140 | Bicuspid aortic valve (HP:0001647) | 1.84723036 |
| 141 | Abnormality of iron homeostasis (HP:0011031) | 1.83653702 |
| 142 | Encephalitis (HP:0002383) | 1.83491534 |
| 143 | Personality changes (HP:0000751) | 1.82406325 |
| 144 | Abnormality of the odontoid process (HP:0003310) | 1.81821696 |
| 145 | Recurrent fungal infections (HP:0002841) | 1.81504733 |
| 146 | Hypoplasia of the odontoid process (HP:0003311) | 1.81339001 |
| 147 | Arthralgia (HP:0002829) | 1.79241842 |
| 148 | Cellulitis (HP:0100658) | 1.78698585 |
| 149 | Short nail (HP:0001799) | 1.78431519 |
| 150 | Premature loss of primary teeth (HP:0006323) | 1.77591585 |
| 151 | Acne (HP:0001061) | 1.77465788 |
| 152 | Episodic fever (HP:0001954) | 1.76411004 |
| 153 | Abnormality of the pleura (HP:0002103) | 1.75448316 |
| 154 | Vertigo (HP:0002321) | 1.74836340 |
| 155 | Polygenic inheritance (HP:0010982) | 1.74366125 |
| 156 | Abnormality of T cell number (HP:0011839) | 1.74364437 |
| 157 | Broad ribs (HP:0000885) | 1.73931153 |
| 158 | Hyperextensible skin (HP:0000974) | 1.73656161 |
| 159 | Short 4th metacarpal (HP:0010044) | 1.73238039 |
| 160 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 1.73238039 |
| 161 | Abnormality of the pericardium (HP:0001697) | 1.72290762 |
| 162 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.71880992 |
| 163 | Metaphyseal cupping (HP:0003021) | 1.71511993 |
| 164 | Pulmonary embolism (HP:0002204) | 1.71258469 |
| 165 | Severe short stature (HP:0003510) | 1.70535437 |
| 166 | Abnormality of the ischium (HP:0003174) | 1.70335493 |
| 167 | Abnormality of the nasal mucosa (HP:0000433) | 1.70203779 |
| 168 | Hypoplastic ischia (HP:0003175) | 1.68924036 |
| 169 | Cardiomegaly (HP:0001640) | 1.68598708 |
| 170 | Arterial thrombosis (HP:0004420) | 1.66254929 |
| 171 | Recurrent bacterial skin infections (HP:0005406) | 1.65523655 |
| 172 | Flat acetabular roof (HP:0003180) | 1.64822121 |
| 173 | Capillary hemangiomas (HP:0005306) | 1.64561641 |
| 174 | Orchitis (HP:0100796) | 1.64545266 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | KDR | 5.66381059 |
| 2 | IRAK3 | 5.38014992 |
| 3 | TGFBR2 | 4.74533283 |
| 4 | LATS2 | 3.85132566 |
| 5 | TIE1 | 3.60972882 |
| 6 | TAOK2 | 3.56222243 |
| 7 | NME2 | 3.21358797 |
| 8 | PRPF4B | 3.13595034 |
| 9 | ERN1 | 3.07983602 |
| 10 | MOS | 2.88653955 |
| 11 | TRIB3 | 2.57908705 |
| 12 | IRAK4 | 2.57214535 |
| 13 | LATS1 | 2.48269973 |
| 14 | MAP3K3 | 2.19863395 |
| 15 | TAOK1 | 2.16843242 |
| 16 | RIPK4 | 2.06651005 |
| 17 | STK10 | 2.03201392 |
| 18 | TYK2 | 1.99069678 |
| 19 | ARAF | 1.95583015 |
| 20 | EEF2K | 1.86548770 |
| 21 | FGR | 1.86170082 |
| 22 | TGFBR1 | 1.84383767 |
| 23 | PAK4 | 1.71550575 |
| 24 | JAK1 | 1.64990609 |
| 25 | NEK9 | 1.60175164 |
| 26 | ERBB4 | 1.55007779 |
| 27 | TTN | 1.53462782 |
| 28 | STK38L | 1.52727046 |
| 29 | MAP3K13 | 1.48428209 |
| 30 | TBK1 | 1.48226854 |
| 31 | PKN2 | 1.42322925 |
| 32 | PIM2 | 1.41568326 |
| 33 | JAK3 | 1.38408928 |
| 34 | CSF1R | 1.38187700 |
| 35 | IRAK2 | 1.36666884 |
| 36 | GRK7 | 1.31995361 |
| 37 | PRKD3 | 1.31345689 |
| 38 | MAP3K14 | 1.26380982 |
| 39 | CDC42BPA | 1.25752292 |
| 40 | CHUK | 1.24577305 |
| 41 | BCKDK | 1.22104379 |
| 42 | PDGFRA | 1.17747980 |
| 43 | KSR2 | 1.16951349 |
| 44 | FGFR4 | 1.16947582 |
| 45 | ZAP70 | 1.12763066 |
| 46 | CDK8 | 1.11200304 |
| 47 | PTK6 | 1.05438825 |
| 48 | EPHB1 | 1.05309159 |
| 49 | RPS6KA4 | 1.05150499 |
| 50 | IKBKB | 1.04519300 |
| 51 | SIK3 | 1.02325782 |
| 52 | MAP3K5 | 0.99888307 |
| 53 | BMX | 0.99298505 |
| 54 | KIT | 0.98676329 |
| 55 | STK3 | 0.96198915 |
| 56 | IRAK1 | 0.93452853 |
| 57 | PTK2B | 0.93393619 |
| 58 | JAK2 | 0.90257473 |
| 59 | BRAF | 0.89766440 |
| 60 | MAPKAPK3 | 0.89137575 |
| 61 | MAP3K8 | 0.89128173 |
| 62 | DDR2 | 0.89010493 |
| 63 | MAP4K1 | 0.84975768 |
| 64 | TESK1 | 0.84756451 |
| 65 | TESK2 | 0.83213493 |
| 66 | MAP3K10 | 0.81993922 |
| 67 | LYN | 0.80970267 |
| 68 | MAP3K6 | 0.80245150 |
| 69 | TXK | 0.75462181 |
| 70 | LRRK2 | 0.72182514 |
| 71 | FES | 0.71666746 |
| 72 | INSRR | 0.71453401 |
| 73 | DYRK1B | 0.70821104 |
| 74 | CDK9 | 0.69681104 |
| 75 | MAPK15 | 0.69669858 |
| 76 | MAP2K3 | 0.68876698 |
| 77 | PAK2 | 0.67870847 |
| 78 | BLK | 0.67614837 |
| 79 | SYK | 0.67381222 |
| 80 | RAF1 | 0.67218516 |
| 81 | PTK2 | 0.66943247 |
| 82 | RET | 0.66447398 |
| 83 | DYRK3 | 0.65794113 |
| 84 | SCYL2 | 0.63084714 |
| 85 | ADRBK2 | 0.60246208 |
| 86 | TRPM7 | 0.59377948 |
| 87 | SIK1 | 0.58867666 |
| 88 | EPHA3 | 0.58793200 |
| 89 | DAPK3 | 0.58071938 |
| 90 | MARK3 | 0.57433769 |
| 91 | FER | 0.56446141 |
| 92 | CSK | 0.55270662 |
| 93 | SMG1 | 0.53675375 |
| 94 | LCK | 0.52593806 |
| 95 | ABL2 | 0.52517542 |
| 96 | MAP3K11 | 0.52456547 |
| 97 | RPS6KC1 | 0.52281462 |
| 98 | RPS6KL1 | 0.52281462 |
| 99 | MAPK12 | 0.49700694 |
| 100 | FGFR3 | 0.48825504 |
| 101 | DMPK | 0.48187969 |
| 102 | MAPK4 | 0.46433436 |
| 103 | TYRO3 | 0.46432409 |
| 104 | PAK1 | 0.45279630 |
| 105 | PDGFRB | 0.45123808 |
| 106 | IGF1R | 0.44764949 |
| 107 | BTK | 0.42463589 |
| 108 | TNK2 | 0.42213569 |
| 109 | DAPK2 | 0.42018236 |
| 110 | NEK1 | 0.41859116 |
| 111 | CAMKK2 | 0.41232153 |
| 112 | BMPR2 | 0.39349663 |
| 113 | PIM1 | 0.38738093 |
| 114 | MATK | 0.38682307 |
| 115 | PKN1 | 0.38098804 |
| 116 | PAK6 | 0.38031217 |
| 117 | EPHB2 | 0.37681745 |
| 118 | PRKD1 | 0.36837713 |
| 119 | MAP3K9 | 0.36796824 |
| 120 | RPS6KA6 | 0.35827892 |
| 121 | MAPK7 | 0.35349951 |
| 122 | PRKAA2 | 0.34815516 |
| 123 | MAP2K1 | 0.34721754 |
| 124 | RIPK1 | 0.34499726 |
| 125 | CDK6 | 0.33627117 |
| 126 | CAMK1D | 0.32581658 |
| 127 | ICK | 0.32308958 |
| 128 | EGFR | 0.32148444 |
| 129 | ILK | 0.31510702 |
| 130 | PRKG2 | 0.31244208 |
| 131 | MAPKAPK2 | 0.30178198 |
| 132 | PDK2 | 0.29748068 |
| 133 | MELK | 0.28671086 |
| 134 | INSR | 0.27747189 |
| 135 | PDPK1 | 0.26284013 |
| 136 | RPS6KA2 | 0.26254579 |
| 137 | PRKCD | 0.26102318 |
| 138 | MTOR | 0.26025398 |
| 139 | MAP3K1 | 0.25863189 |
| 140 | MARK2 | 0.25723854 |
| 141 | MAPK11 | 0.24676135 |
| 142 | IKBKE | 0.24507850 |
| 143 | GSK3A | 0.24496975 |
| 144 | HCK | 0.24256257 |
| 145 | HIPK2 | 0.23574290 |
| 146 | RPS6KA1 | 0.23417689 |
| 147 | PDK1 | 0.22352361 |
| 148 | STK16 | 0.21497595 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 3.14820968 |
| 2 | Other glycan degradation_Homo sapiens_hsa00511 | 2.92971579 |
| 3 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.65195388 |
| 4 | Malaria_Homo sapiens_hsa05144 | 2.19217498 |
| 5 | Allograft rejection_Homo sapiens_hsa05330 | 2.18563126 |
| 6 | Leishmaniasis_Homo sapiens_hsa05140 | 2.00428525 |
| 7 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.99724620 |
| 8 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.93612679 |
| 9 | * Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.83062341 |
| 10 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.80624398 |
| 11 | Asthma_Homo sapiens_hsa05310 | 1.78262447 |
| 12 | Prion diseases_Homo sapiens_hsa05020 | 1.76627826 |
| 13 | Lysosome_Homo sapiens_hsa04142 | 1.73966600 |
| 14 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.68540050 |
| 15 | Focal adhesion_Homo sapiens_hsa04510 | 1.66068835 |
| 16 | Shigellosis_Homo sapiens_hsa05131 | 1.65509934 |
| 17 | Adherens junction_Homo sapiens_hsa04520 | 1.61128889 |
| 18 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.59479863 |
| 19 | Pertussis_Homo sapiens_hsa05133 | 1.56978835 |
| 20 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.56908572 |
| 21 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.55657037 |
| 22 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.55348024 |
| 23 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.55007115 |
| 24 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.53151008 |
| 25 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.52165722 |
| 26 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.50693361 |
| 27 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.50627527 |
| 28 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.47525375 |
| 29 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.47162206 |
| 30 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.47022239 |
| 31 | Viral myocarditis_Homo sapiens_hsa05416 | 1.45659324 |
| 32 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.45150645 |
| 33 | Apoptosis_Homo sapiens_hsa04210 | 1.33650232 |
| 34 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.32847957 |
| 35 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.31325910 |
| 36 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.31013491 |
| 37 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.28954422 |
| 38 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.27828864 |
| 39 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.26549116 |
| 40 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.26289820 |
| 41 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 1.23090273 |
| 42 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.20986565 |
| 43 | Bladder cancer_Homo sapiens_hsa05219 | 1.20787700 |
| 44 | Legionellosis_Homo sapiens_hsa05134 | 1.19834657 |
| 45 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.17677163 |
| 46 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 1.15365925 |
| 47 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.12175416 |
| 48 | Hepatitis C_Homo sapiens_hsa05160 | 1.09655726 |
| 49 | Tuberculosis_Homo sapiens_hsa05152 | 1.07497710 |
| 50 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.07054156 |
| 51 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 1.06759596 |
| 52 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.04382613 |
| 53 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.03445732 |
| 54 | Influenza A_Homo sapiens_hsa05164 | 1.03416950 |
| 55 | Melanoma_Homo sapiens_hsa05218 | 1.03082151 |
| 56 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.01068773 |
| 57 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.99308127 |
| 58 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.99266186 |
| 59 | Salmonella infection_Homo sapiens_hsa05132 | 0.94960140 |
| 60 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.93085698 |
| 61 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.92751103 |
| 62 | HTLV-I infection_Homo sapiens_hsa05166 | 0.91757224 |
| 63 | Measles_Homo sapiens_hsa05162 | 0.90233303 |
| 64 | Hepatitis B_Homo sapiens_hsa05161 | 0.89565948 |
| 65 | Amoebiasis_Homo sapiens_hsa05146 | 0.89049267 |
| 66 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.88915656 |
| 67 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.88736230 |
| 68 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.88334913 |
| 69 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.85166400 |
| 70 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.83757438 |
| 71 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.82775696 |
| 72 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.81935826 |
| 73 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.81867798 |
| 74 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.80209284 |
| 75 | Colorectal cancer_Homo sapiens_hsa05210 | 0.78890060 |
| 76 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.78368731 |
| 77 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.77260596 |
| 78 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.76290812 |
| 79 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.76025254 |
| 80 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.75964571 |
| 81 | Platelet activation_Homo sapiens_hsa04611 | 0.75150475 |
| 82 | Pathways in cancer_Homo sapiens_hsa05200 | 0.74974952 |
| 83 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.74914594 |
| 84 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.74106346 |
| 85 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.72579492 |
| 86 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.71612667 |
| 87 | Phagosome_Homo sapiens_hsa04145 | 0.71358366 |
| 88 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.70374961 |
| 89 | Galactose metabolism_Homo sapiens_hsa00052 | 0.67545609 |
| 90 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.67169752 |
| 91 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.66645554 |
| 92 | Glioma_Homo sapiens_hsa05214 | 0.65501240 |
| 93 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.65461501 |
| 94 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.65386386 |
| 95 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.64690033 |
| 96 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.63737628 |
| 97 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.63344497 |
| 98 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.60695415 |
| 99 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.60322131 |
| 100 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.60272832 |
| 101 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.60255062 |
| 102 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.60082835 |
| 103 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.59733593 |
| 104 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.59554453 |
| 105 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.58840950 |
| 106 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.56724092 |
| 107 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.55554860 |
| 108 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.54735138 |
| 109 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.54359061 |
| 110 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.52939795 |
| 111 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.52912116 |
| 112 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.52479406 |
| 113 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.51873588 |
| 114 | Endometrial cancer_Homo sapiens_hsa05213 | 0.50168219 |
| 115 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.50134426 |
| 116 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.49050809 |
| 117 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.48784938 |
| 118 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.47761917 |
| 119 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.47087360 |
| 120 | Prostate cancer_Homo sapiens_hsa05215 | 0.46995339 |
| 121 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.46236892 |
| 122 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.46011729 |
| 123 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.45827150 |
| 124 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.38668041 |
| 125 | Endocytosis_Homo sapiens_hsa04144 | 0.35203875 |
| 126 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.35149803 |
| 127 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.34430722 |
| 128 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.27978908 |
| 129 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.24502565 |
| 130 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.22498955 |
| 131 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.19312409 |
| 132 | Insulin resistance_Homo sapiens_hsa04931 | 0.19206604 |
| 133 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.18297851 |

